Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Codebase Ventures receives positive technical study results for hydroxychloroquine patch technology

% of readers think this story is Fact. Add your two cents.


Codebase Ventures Inc (CSE:CODE) (FRA:C5B) (OTCQB:BKLLF) on Thursday provided an update on the continued development of its proposed transdermal delivery technology for hydroxychloroquine (HCQ). 

The company said it had engaged TRPL (Transdermal Research Pharm Laboratories) of Long Island City, New York, to conduct a feasibility study — which indicates that HCQ has all the required parameters to be a transdermal candidate. 

Moreover, in recognition of the potential value of this legacy asset and in light of the company’s current focus on the blockchain and related emerging technology ecosystem, Codebase said it is investigating spinning out its interest in the transdermal delivery technology for HCQ. 

READ: Codebase Ventures explores non-fungible token investments

Codebase said details on any such spin-out will be provided in the coming weeks as it explores deal structures with its partners to ensure its shareholders benefit. 

Codebase noted that it has a 49% interest in Glanis Pharmaceuticals Inc, an arms-length private company that holds provisional US patents for transdermal and oral mucosal delivery of hydroxychloroquine and chloroquine (CQ). The drug has been approved by the US Food and Drug Administration (FDA) as a treatment against malaria, lupus, and rheumatoid arthritis.

On the basis of positive results from the feasibility study, Codebase said the parties are beginning the process from a provisional to a full patent.

Highlights include:

  • The market for HCQ forecast to reach $6 billion by 2027 as FDA-approved treatment for malaria, lupus, and rheumatoid arthritis;
  • Codebase receives positive technical feasibility study results indicating HCQ has all the required parameters to be delivered transdermally; and
  • HCQ transdermal treatment for malaria, lupus, and rheumatoid arthritis patients likely to resolve oral tablet side effects as it would bypass the first-pass metabolism.

Meanwhile, Codebase said it has received interest in the application of HCQ in a transdermal patch for underserved patients with malaria, lupus, and rheumatoid arthritis, as current oral tablet delivery of HCQ comes with side effects that transdermal delivery is likely to resolve.

Transdermal delivery can provide a drug plasma concentration at a predetermined rate for a predetermined period of time, Codebase said. Safe, consistent doses will make the drug much more effective at reduced dosages required because the GI system is avoided. 

Codebase said this new delivery method should eliminate or reduce the number of the common side effects of the oral tablet treatment, including nausea, vomiting, loss of appetite, diarrhea, dizziness, or headache, by providing controlled constant delivery.

Contact the author: [email protected]

Follow him on Twitter @PatrickMGraham

Story by ProactiveInvestors



Source: http://www.proactiveinvestors.com/companies/news/945622/codebase-ventures-receives-positive-technical-study-results-for-hydroxychloroquine-patch-technology-945622.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Please Help Support BeforeitsNews by trying our Natural Health Products below!


Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST


Order by Phone at 888-809-8385 or online at https://www.herbanomic.com M - F 9am to 5pm EST


Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!

HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation

Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.

MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser!  Cleans out toxic buildup with oxygen! 
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover -  Reduces Smart Meter radiation by 96%!  (See Video)

Immusist Beverage Concentrate - Proprietary blend, formulated to reduce inflammation while hydrating and oxygenating the cells.

Report abuse
Loading...

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.